|Study marks the emergence of disease-modifying treatments for autism spectrum disorders|
|December 16, 2010|
|Boston, Mass. -- Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls. The drug, mecasermin, a synthetic form of insulin-like growth factor-1 (IGF-1), is already FDA-approved for children with short stature due to IGF-1 deficiency.|
Exceptional team gives tribute to a very special girl after a 12 year partnership - We have been blessed to be in a small, caring community. Tori started school on my campus at the age of 3. She was mainstreamed in a regular education clas...
3 weeks ago